We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$41.7M
(-20%)
Cap. Flow
-$37.4M
Cap. Flow
% of AUM
-22.99%
Top 10 Holdings %
Top 10 Hldgs %
67.12%
Holding
128
New
40
Increased
32
Reduced
13
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dropbox
DBX
|
+$1.92M |
| 2 |
SNCR
Synchronoss Technologies
SNCR
|
+$1.8M |
| 3 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.62M |
| 4 |
Silicom
SILC
|
+$1.38M |
| 5 |
CYBE
Cyberoptics Corp
CYBE
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teladoc Health
TDOC
|
+$3.25M |
| 2 |
ON Semiconductor
ON
|
+$1.95M |
| 3 |
Nutanix
NTNX
|
+$1.56M |
| 4 |
FLNA
Filana Therapeutics
FLNA
|
+$1.22M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.04% |
| 2 | Healthcare | 6.42% |
| 3 | Industrials | 2.39% |
| 4 | Consumer Discretionary | 1% |
| 5 | Communication Services | 0.1% |
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Worth Venture Partners held 128 positions worth $162M, down 20% from $204M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Worth Venture Partners withdrew a net $37.4M in Q1 2020, closing 25 positions and reducing 13 holdings. Its most notable exit was Teladoc Health, an estimated $3.25M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8% of assets, up from 6.9% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Worth Venture Partners opened a new position in Dropbox worth $1.91M.
- Worth Venture Partners's largest Q1 2020 buy was Dropbox: 105,750 shares worth $1.91M.
- Worth Venture Partners added most to Synchronoss Technologies in Q1 2020, an estimated $1.8M increase.
- Worth Venture Partners's biggest Q1 2020 reduction was Filana Therapeutics, cutting an estimated $1.22M.
- Worth Venture Partners fully exited Teladoc Health in Q1 2020, selling an estimated $3.25M.
- Worth Venture Partners's ten largest holdings make up 67% of its $162M portfolio in Q1 2020.
- Worth Venture Partners opened 40 new positions and closed 25 in Q1 2020.
- Worth Venture Partners's portfolio value fell 20% quarter-over-quarter to $162M.
Based on Worth Venture Partners's 13F filing for Q1 2020, filed 15 May 2020.